No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
108 (estimated)
Sponsor
Instituto Mexicano del Seguro Social · Government
Who this trial is looking for
This trial is looking for people who are set to have weight loss surgery again. Participants will receive a special green fluorescent product during the surgery to help identify blood vessels.
Are You a Good Fit for This Trial?
Rules you outLiver disease
You may be able to join if
I have been diagnosed with obesity.
I have a BMI of 30 or higher.
I am scheduled for revisional bariatric surgery.
You may not be able to join if
I am allergic to iodides.
I use anticoagulants with sodium bisulfite.
I had radioactive iodine studies in the past 7 days.
I am pregnant, breastfeeding, or planning to become pregnant in the next year.
I have a history of liver disease.
My bilirubin level is above 1.5 times the normal limit.
My AST level is above the normal limit.
I have withdrawn my consent to participate.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This study will compare different doses of a green fluorescent product that is administered during weight loss surgery in order to observe where blood vessels are located. There is uncertainty around the optimal dose of this product for patients with obesity, so this study will aim to study if the dose in the minimal range recommended by international guidelines is sufficient for most patients or …
This study will compare different doses of a green fluorescent product that is administered during weight loss surgery in order to observe where blood vessels are located. There is uncertainty around the optimal dose of this product for patients with obesity, so this study will aim to study if the dose in the minimal range recommended by international guidelines is sufficient for most patients or if higher doses are needed with increasing body mass index.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of obesity with a BMI ≥ 30 kg/m²
* Scheduled for revisional bariatric surgery
Exclusion Criteria:
* Allergy to iodides.
* Anticoagulation with products containing sodium bisulfite (due to the risk of ICG-FA inactivation).
* Use of radioactive iodine studies within …
Inclusion Criteria:
* Diagnosis of obesity with a BMI ≥ 30 kg/m²
* Scheduled for revisional bariatric surgery
Exclusion Criteria:
* Allergy to iodides.
* Anticoagulation with products containing sodium bisulfite (due to the risk of ICG-FA inactivation).
* Use of radioactive iodine studies within the past 7 days.
* Pregnant, breastfeeding, or planning to become pregnant within the next year (due to unknown teratogenic or fertility effects of ICG-FA).
* History of liver disease or laboratory findings suggestive of moderate to severe hepatic disease: total bilirubin \>1.5 times the upper limit of normal (ULN), or any elevation of aspartate aminotransferase (AST) above ULN.
* Participants who withdraw their consent to participate in the study (elimination criterion).
Contacts
No contact information available.
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.